These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 10624905

  • 1. Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndrome.
    Matzkies FK, Cullen P, Schaefer L, Hartmann M, Hohage H, Schaefer RM.
    South Med J; 1999 Dec; 92(12):1157-61. PubMed ID: 10624905
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Central role of zinc protoporphyrin in staging iron deficiency.
    Hastka J, Lasserre JJ, Schwarzbeck A, Hehlmann R.
    Clin Chem; 1994 May; 40(5):768-73. PubMed ID: 8174250
    [Abstract] [Full Text] [Related]

  • 4. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients.
    Braun J, Lindner K, Schreiber M, Heidler RA, Hörl WH.
    Nephrol Dial Transplant; 1997 Jun; 12(6):1173-81. PubMed ID: 9198047
    [Abstract] [Full Text] [Related]

  • 5. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy.
    Schaefer RM, Schaefer L.
    J Perinat Med; 1995 Jun; 23(1-2):83-8. PubMed ID: 7658326
    [Abstract] [Full Text] [Related]

  • 6. [Red cell zinc protoporphyrin and its ratio to serum ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal failure on hemodialysis].
    Matuszkiewicz-Rowińska J, Ostrowski G, Niemczyk S, Przedlacki J, Wardyn K, Puka J, Włodarczyk D, Switalski M, Zakrzewska T, Ostrowski K.
    Pol Arch Med Wewn; 2003 Jul; 110(1):703-10. PubMed ID: 14682204
    [Abstract] [Full Text] [Related]

  • 7. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
    Tarng DC, Wei YH, Huang TP, Kuo BI, Yang WC.
    Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin.
    Tessitore N, Solero GP, Lippi G, Bassi A, Faccini GB, Bedogna V, Gammaro L, Brocco G, Restivo G, Bernich P, Lupo A, Maschio G.
    Nephrol Dial Transplant; 2001 Jul; 16(7):1416-23. PubMed ID: 11427634
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients.
    Fishbane S, Lynn RI.
    Am J Kidney Dis; 1995 Mar; 25(3):426-32. PubMed ID: 7872320
    [Abstract] [Full Text] [Related]

  • 12. Assessment of iron status by erythrocyte ferritin in uremic patients with or without recombinant human erythropoietin therapy.
    Caravaca F, Vagace JM, Aparicio A, Groiss J, Pizarro JL, Alonso N, Garcia MC, Arrobas M, Cubero J, Esparrago J.
    Am J Kidney Dis; 1992 Sep; 20(3):249-54. PubMed ID: 1519605
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Erythrocyte zinc protoporphyrin.
    Braun J.
    Kidney Int Suppl; 1999 Mar; 69():S57-60. PubMed ID: 10084287
    [Abstract] [Full Text] [Related]

  • 16. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.
    Baldus M, Walter H, Thies K, Anders C, Stein M, Hellstern P, Brass H.
    Clin Nephrol; 1998 Mar; 49(3):186-92. PubMed ID: 9543601
    [Abstract] [Full Text] [Related]

  • 17. Iron supplementation in haemodialysis--practical clinical guidelines.
    Silva J, Andrade S, Ventura H, Santos JP, Colaço S, Oliveira C, Ponce P.
    Nephrol Dial Transplant; 1998 Oct; 13(10):2572-7. PubMed ID: 9794562
    [Abstract] [Full Text] [Related]

  • 18. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
    Canavese C, Grill A, Decostanzi E, Maddalena E, Barbieri S, Martina G, Fop F, Buglione E, Grechi D, David O, Saitta M, Piccoli G.
    Clin Nephrol; 2000 Jan; 53(1):42-7. PubMed ID: 10661481
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic utility of zinc protoporphyrin to detect iron deficiency in Kenyan pregnant women.
    Mwangi MN, Maskey S, Andang o PE, Shinali NK, Roth JM, Trijsburg L, Mwangi AM, Zuilhof H, van Lagen B, Savelkoul HF, Demir AY, Verhoef H.
    BMC Med; 2014 Nov 26; 12():229. PubMed ID: 25428714
    [Abstract] [Full Text] [Related]

  • 20. [Economic assessment of iron deficiency. Replacement of ferritin and serum iron by other parameters].
    Kutter D, Kremer A.
    Bull Soc Sci Med Grand Duche Luxemb; 2001 Nov 26; (1):17-27. PubMed ID: 11570210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.